2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
117
Colonic Neoplasms
30
Neoplasm Metastasis
28
Rectal Neoplasms
27
Neoplasms
27
Carcinoma, Non-Small-Cell Lung
14
Esophageal Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Pancreatic Neoplasms
9
Head and Neck Neoplasms
9
Lung Neoplasms
8
Cholangiocarcinoma
7
Colorectal Cancer Metastatic
6
Carcinoma, Squamous Cell
6
Breast Neoplasms
6
Carcinoma
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Inflammatory Breast Neoplasms
3
Gastrointestinal Neoplasms
3
Adenocarcinoma Of Esophagus
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Solid Tumors
2
Kidney Neoplasms
2
Glioma
2
Fallopian Tube Neoplasms
2
Interventions
Gels
2
Fulvestrant
2
Doxycycline
2
Dapsone
2
ruxolitinib
1
dexpanthenol
1
ceterizine hydrochloride
1
capivasertib
1
benralizumab
1
Triamcinolone Acetonide
1
Tetracycline
1
Sirolimus
1
Provitamins
1
Prednisone
1
Panitumumab
1
Minocycline
1
Loperamide
1
Irinotecan
1
Interviews as Topic
1
IFL protocol
1
Hydrocortisone
1
HIV Testing
1
Fibroblast Growth Factor 7
1
Erlotinib Hydrochloride
1
Clindamycin
1
Cetuximab
1
Anti-Bacterial Agents
1
Alpelisib
1
Acitretin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Exanthema
×
Panitumumab
×
Clear all
NCT00332163
2016-02-23
STEPP
Amgen
Phase 2
Completed
95 enrolled
23 charts